2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$59.73+$0.23 (+0.39%)
Price as of Aug 21, 2026 7:59 PM EDT- $5.9BMarket Cap
- 9.54%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$59.73+$0.23 (+0.39%)
CRSP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $59.50 | ||
Change | +$1.38 (+2.37%) | ||
Open | $59.72 | ||
High | $62.53 | ||
Low | $58.89 | ||
Previous Close | $58.12 | ||
Volume | 2,453,842 | ||
30-Day Average Volume | 1,607,072 | ||
1-Week Change | 11.11% | ||
1-Month Change | 23.57% | ||
1-Year Change | 9.54% | ||
3-Year Change | 24.14% | ||
5-Year Change | -49.24% | ||
Fundamentals | |||
Shares Outstanding | 98.6M | ||
Total Assets | $2.7B | ||
Market Cap | $5.9B | ||
Enterprise Value | $6.2B | ||
Period: QTR TTM FY | |||
Revenue | $10.0M | ||
Net Income | -$91.2M | ||
Free Cash Flow | -$84.1M | ||
EBIT | -$86.9M | ||
EBITDA | -$82.6M | ||
Net Working Capital | $2.2B | ||
EPS | -$0.94 | ||
Enterprise Value/EBITDA | -75 | ||
Enterprise Value/Revenue | 616 | ||
P/B | 3 | ||
P/E | -63 | ||
PEG | -2 | ||
Price/Free Cash Flow | -70 | ||
Price/Operating Cash Flow | -70 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue